Comparison of genetic variation of breast cancer susceptibility genes in chinese and german populations

European Journal of Human Genetics

Volumn 21, Issue 11, 2013, Pages 1286-1292

  Barzan, David ^a,d   Veldwijk, Marlon R ^a   Herskind, Carsten ^a   Li, Yang ^b,c   Zhang, Bo ^a   Sperk, Elena ^a   Du, Wei Dong ^b,c   Zhang, Xue Jun ^b,c   Wenz, Frederik ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c Ministry of National Science and Technology   (China)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

association studies; breast cancer; Chinese population; German population; single nucleotide polymorphism (SNP)

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SUSCEPTIBILITY; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; ETHNIC GROUP; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; GERMAN; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; ESTROGEN RECEPTOR ALPHA; FEMALE; GENES, NEOPLASM; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPING TECHNIQUES; GERMANY; HAPLOTYPES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, PROGESTERONE;

EID: 84885921350     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2013.38     Document Type: Article

References (45)

1. Key TJ, Verkasalo PK, Banks E: Epidemiology of breast cancer. Lancet Oncol 2001; 2: 133-140. (Pubitemid 33585924)
2. Fletcher O, Houlston RS: Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 2010; 10: 353-361.
3. Narod SA: Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer 2002; 2: 113-123. (Pubitemid 37328798)
4. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101 986 women without the disease. Lancet 2001; 358: 1389-1399.
5. Peto J, Mack TM: High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 2000; 26: 411-414.
6. Lichtenstein P, Holm NV, Verkasalo PK et al: Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85. (Pubitemid 30451850)
7. Kirova YM, Savignoni A, Sigal-Zafrani B et al: Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature. Breast Cancer Res Treat 2010; 120: 119-126.
8. Zhang B, Beeghly-Fadiel A, Long J, Zheng W: Genetic variants associated with breastcancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol 2011; 12: 477-488.
9. Stratton MR, Rahman N: The emerging landscape of breast cancer susceptibility. Nat Genet 2008; 40: 17-22.
10. Pharoah PD, Antoniou AC, Easton DF, Ponder BA: Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 2008; 358: 2796-2803. (Pubitemid 351930854)
11. McCarthy MI, Abecasis GR, Cardon LR et al: Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008; 9: 356-369. (Pubitemid 351556063)
12. Jin F, Devesa SS, Chow WH et al: Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer 1999; 83: 435-440. (Pubitemid 29489855)
13. Linos E, Spanos D, Rosner BA et al: Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J Natl Cancer Inst 2008; 100: 1352-1360.
14. Zheng W, Wen W, Gao YT et al: Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst 2010; 102: 972-981.
15. Rosenberg NA, Huang L, Jewett EM, Szpiech ZA, Jankovic I, Boehnke M: Genomewide association studies in diverse populations. Nat Rev Genet 2010; 11: 356-366.
16. Freedman ML, Monteiro AN, Gayther SA et al: Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 2011; 43: 513-518.
17. Tchatchou S, Jung A, Hemminki K et al: A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis 2009; 30: 59-64.
18. Yang R, Dick M, Marme F et al: Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk. Breast Cancer Res Treat 2011; 127: 549-554.
19. Frank B, Wiestler M, Kropp S et al: Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. J Natl Cancer Inst 2008; 100: 437-442. (Pubitemid 351480514)
20. Ahmed S, Thomas G, Ghoussaini M et al: Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009; 41: 585-590.
21. Easton DF, Pooley KA, Dunning AM et al: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007; 447: 1087-1093. (Pubitemid 47014426)
22. Gold B, Kirchhoff T, Stefanov S et al: Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci USA 2008; 105: 4340-4345. (Pubitemid 351754382)
23. Hunter DJ, Kraft P, Jacobs KB et al: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007; 39: 870-874. (Pubitemid 47014500)
24. Murabito JM, Rosenberg CL, Finger D et al: A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study. BMC Med Genet 2007; 8:Suppl 1 S6.
25. Stacey SN, Manolescu A, Sulem P et al: Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2008; 40: 703-706. (Pubitemid 351748861)
26. Thomas G, Jacobs KB, Kraft P et al: A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 2009; 41: 579-584.
27. Turnbull C, Ahmed S, Morrison J et al: Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010; 42: 504-507.
28. Long J, Cai Q, Shu XO et al: Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genet 2010; 6: e1001002.
29. Zheng W, Long J, Gao YTet al: Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 2009; 41: 324-328.
30. Stacey SN, Manolescu A, Sulem P et al: Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007; 39: 865-869. (Pubitemid 47014497)
31. Long J, Cai Q, Sung H et al: Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet 2012; 8: e1002532.
32. Cai Q, Shu XO, Jin F et al: Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2003; 12: 853-859. (Pubitemid 37151519)
33. Cai Q, Gao YT, Wen W et al: Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene. Cancer Res 2003; 63: 5727-5730. (Pubitemid 37187468)
34. Shin A, Kang D, Nishio H et al: Estrogen receptor alpha gene polymorphisms and breast cancer risk. Breast Cancer Res Treat 2003; 80: 127-131. (Pubitemid 36851292)
35. Andersen TI, Heimdal KR, Skrede M, Tveit K, Berg K, Borresen AL: Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet 1994; 94: 665-670. (Pubitemid 24351525)
36. Gold B, Kalush F, Bergeron J et al: Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res 2004; 64: 8891-8900. (Pubitemid 39665494)
37. Gilbert E, Del Gatto F, Champion-Arnaud P, Gesnel MC, Breathnach R: Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA. Mol Cell Biol 1993; 13: 5461-5468. (Pubitemid 23260649)
38. Adnane J, Gaudray P, Dionne CA et al: BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 1991; 6: 659-663. (Pubitemid 21924133)
39. Moffa AB, Tannheimer SL, Ethier SP: Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells. Mol Cancer Res 2004; 2: 643-652. (Pubitemid 39557667)
40. Tannheimer SL, Rehemtulla A, Ethier SP: Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE. Breast Cancer Res 2000; 2: 311-320. (Pubitemid 32223612)
41. Zhang Y, Gorry MC, Post JC, Ehrlich GD: Genomic organization of the human fibroblast growth factor receptor 2 (FGFR2) gene and comparative analysis of the human FGFR gene family. Gene 1999; 230: 69-79. (Pubitemid 29193197)
42. Tamaru N, Hishikawa Y, Ejima K et al: Estrogen receptor-associated expression of keratinocyte growth factor and its possible role in the inhibition of apoptosis in human breast cancer. Lab Invest 2004; 84: 1460-1471. (Pubitemid 39482163)
43. Cleton-Jansen AM, Buerger H, Haar N et al: Different mechanisms of chromosome 16 loss of heterozygosity in well-versus poorly differentiated ductal breast cancer. Genes Chromosomes Cancer 2004; 41: 109-116. (Pubitemid 39096736)
44. Rakha EA, Green AR, Powe DG, Roylance R, Ellis IO: Chromosome 16 tumor-suppressor genes in breast cancer. Genes Chromosomes Cancer 2006; 45: 527-535. (Pubitemid 43727159)
45. O'Flaherty E, Kaye J: TOX defines a conserved subfamily of HMG-box proteins. BMC Genomics 2003; 4: 13.